Tag: inflammatory disorders

Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline

pallavi123- February 16, 2022

Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More

Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal

pharmanewsdaily- January 12, 2021

Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage biopharma ... Read More